| ID | Sequence | Length | GC content |
|---|---|---|---|
| NEXN-AS1:1 | UUUCACAAUUUACAAACAGCUGGAAUGGUUUGGCGUUUUCAAAAGCAUA… | 2292 nt | 0.5301 |
| NEXN-AS1:2 | CACACUCGGAGUAUUUUUGGUGGACGAGAUCUUUAAUUCUUCACUGCAC… | 731 nt | 0.4378 |
| NEXN-AS1:3 | GAAAGGAUUUCUUAACUGGCACUGCUGGCAGAGACGGAGACCGCGGCUG… | 8399 nt | 0.4641 |
No relevant information is available at the moment.
A study in humans identified that the NEXN-AS1 is reduced in arterial plaques and plays a protective role against atherosclerosis by inhibiting endothelial activation and monocyte recruitment via the TLR4/NF-κB pathway [Chih-Fan Yeh et al. DOI:10.1186/s12929-020-00647-w].